Braun Stacey Associates’s Cerence CRNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-256,315
Closed -$27.4M 133
2021
Q2
$27.4M Buy
256,315
+2,860
+1% +$281K 1.07% 24
2021
Q1
$22.7M Sell
253,455
-65,140
-20% -$7.17M 0.96% 34
2020
Q4
$32M Sell
318,595
-81,590
-20% -$6.08M 1.44% 10
2020
Q3
$19.6M Sell
400,185
-9,835
-2% -$472K 1.05% 24
2020
Q2
$16.7M Buy
410,020
+261,275
+176% +$7.51M 0.96% 37
2020
Q1
$2.29M Buy
+148,745
New +$3.13M 0.17% 100

Other funds holding CRNC

Braun Stacey Associates's CRNC Position: Q3 2021 in Review

Braun Stacey Associates sold out of Cerence (CRNC) in Q3 2021, closing a stake of 256,315 shares — an estimated $27.4M sold.

Braun Stacey Associates first reported a position in CRNC in Q1 2020 and held it in 6 quarters. The position peaked at $32M in Q4 2020. 362 funds tracked by Wall St. Rank hold CRNC as of Q3 2021.

  • Braun Stacey Associates reported no remaining Cerence position as of Q3 2021 after selling out during the quarter.
  • Braun Stacey Associates sold 256,315 Cerence shares in Q3 2021, an estimated $27.4M.
  • Braun Stacey Associates first reported a position in Cerence in Q1 2020 and held it in 6 quarters.
  • Braun Stacey Associates's Cerence position peaked at $32M in Q4 2020.
  • 362 funds tracked by Wall St. Rank held Cerence as of Q3 2021.

Based on Braun Stacey Associates's 13F filing for Q3 2021, filed 1 Dec 2021.